Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Prostatic Neoplasms 2Colorectal Neoplasms 2Otorhinolaryngologic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Localized Head and Neck Carcinoma 1Gastrointestinal Neoplasms 1Disease 1Cardiovascular Diseases 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Bevacizumab 75Fluorouracil 55Cetuximab 47Oxaliplatin 43Leucovorin 43pembrolizumab 35Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 18trifluridine tipiracil drug combination 16Nivolumab 15Blood Specimen Collection 15Panitumumab 14regorafenib 13Magnetic Resonance Spectroscopy 13Trifluridine 12Gemcitabine 12Biopsy 12Standard of Care 11Cisplatin 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 9tislelizumab 8Trastuzumab 8Cyclophosphamide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Referral and Consultation × Clear all
NCT06568016 2026-02-09

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

Jonsson Comprehensive Cancer Center

Phase NA Recruiting
1,500 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05174286 2025-09-16

CHURCH

Columbia University

Phase NA Recruiting
880 enrolled
Gastrointestinal

Cardiovascular Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡